Investigators, REMAP-CAP Writing Committee for the REMAP-CAP ; Dark, Paul Investigators , REMAP-CAP W C F T REMAP-CAP & Dark , P 2022 , ' Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. ' , JAMA , vol. 327 , no. 13 , pp. 1247-1259 . https://doi.org/10.1001/jama.2022.2910.
,
2022
Investigators, REMAP-CAP ; Dark, Paul Investigators , REMAP-CAP & Dark , P 2021 , ' Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. ' , The New England Journal of Medicine , vol. 385 , no. 9 , pp. 790-802 . https://doi.org/10.1056/NEJMoa2105911.
,
2021
Investigators, REMAP-CAP ; Dark, Paul Investigators , REMAP-CAP & Dark , P 2021 , ' Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 ' , The New England Journal of Medicine , vol. 385 , no. 9 , pp. 777-789 . https://doi.org/10.1056/NEJMoa2103417.
,
2021
Investigators, Writing Committee for the REMAP-CAP ; Dark, Paul Investigators , W C F T REMAP-CAP & Dark , P 2023 , ' Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. ' , JAMA . https://doi.org/10.1001/jama.2023.4480.
,
2023
Investigators, Writing Committee for the REMAP-CAP ; Dark, Paul Investigators , W C F T REMAP-CAP & Dark , P 2021 , ' Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial ' , JAMA , vol. 326 , no. 17 , pp. 1690-1702 . https://doi.org/10.1001/jama.2021.18178.
,
2021